The results with the addition of metronomic cyclophosphamide to palliative radiotherapy for the treatment of non-small cell lung carcinoma

BACKGROUND: A considerable proportion of non-small cell lung carcinoma (NSCLC) patients are ineligible for radical therapies. Many are frail not to tolerate intravenous palliative chemotherapy either. These patients often receive palliative radiotherapy (RT), or supportive care alone. We intend to c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Transl Med
Autori principali: Revannasiddaiah, Swaroop, Joshi, Subhash Chandra, Pandey, Kailash Chandra, Rastogi, Madhup, Sharma, Mukesh, Gupta, Manoj
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2015
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4669322/
https://ncbi.nlm.nih.gov/pubmed/26697465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2305-5839.2015.11.25
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi